Neuralstem Inc. (CUR) Stock Research, Analysis & News

Quick Analysis on Neuralstem Inc. (CUR) Stock as of June 28, 2017

Previous Closing Price $5.70 is above 50 day moving average of $4.65
Previous Closing Price $5.70 is above 200 day moving average of $3.78
The Stock pays no dividend
The closing price $5.70 is more than 356.14% away from its one year target price of $26.00
Current Short Ratio 7.60 is great than 1
Earning per Share $-2.35 is negative. Neuralstem Inc. is lossing money.
EBITDA $-18.21M is negative
(See more information about Neuralstem Inc. (CUR) Stock below)

Neuralstem Inc. (CUR) Stock Profile Summary

Neuralstem, Inc., a biopharmaceuticals company, focuses on the development and commercialization of treatments for central nervous system diseases based on transplanting human neural stem cells and small molecule drugs. It uses its proprietary human neural stem cell technology as a tool for use in the small-molecule drug discovery, as well as to create cell therapy biotherapeutics for the treatment of central nervous system diseases, various neurodegenerative conditions, and for the regenerative repair of acute diseases. The company was founded in 1996 and is headquartered in Rockville, Maryland.

Neuralstem Inc. (CUR) Stock Key Statistics Research and Analysis as of June 28, 2017

Stock ExchangeNCM
Market Capitalization$69.85M
Trade Volume (Average Trading Volume)74,589 (93,966)
Current Year EPS Estimate$-2.26
Next Year EPS Estimate$-2.24
Previous Closing Price$5.70
50 Day Price Moving Average$4.65
200 Day Price Moving Average$3.78
1 yr Target Price$26.00
PEG Ratio0.00
Short Ratio7.60

Latest Market News on Neuralstem Inc. (CUR)

Click here to find the latest news on Neuralstem Inc. (CUR)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center